Together, these results suggest that the elevation of ACE2 in TBS-soluble and, to a lesser extent, in microvessel fractions are associated with more advanced Aβ and tau pathologies and with a pattern of changes in vascular proteins consistent with AD progression. Here, MAPT is linked to Alzheimer disease.